Free Trial
LON:HRI

Herald 7/23/2025 Earnings Report

Herald logo
GBX 3,015.24 -29.76 (-0.98%)
As of 12:07 PM Eastern

Herald EPS Results

Actual EPS
GBX 0.77
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Herald Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Herald Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Herald Earnings Headlines

Saba agrees truce with Aberdeen in Herald trust shake-up
BSEM: From OTC to Nasdaq Contender!
BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited financials for 2024 and 2025 - a key step toward its Nasdaq uplisting. The company paired that move with a $40 million acquisition expanding its reach into hospitals and surgical centers, all within a $300M-plus addressable market. Zacks carries a $25.50 price target on the stock.tc pixel
A new chapter for Herald Investment Trust
See More Herald Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Herald? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Herald and other key companies, straight to your email.

About Herald

Herald (LON:HRI) Investment Trust’s objective is to achieve capital appreciation through investments in smaller quoted companies in the areas of technology and communications. Investments may be made across the world. The business activities of investee companies will include information technology, broadcasting, printing and publishing and the supply of equipment and services to these companies.

View Herald Profile